Today’s Solutions: January 16, 2025

Since 2000, malaria mortality rates have fallen by 66% among all ages groups and by 71% among children under five in Africa. The massive drop is a testament to the hard work of malaria prevention workers, but there is still much work to be done to rid the world of the disease. A new vaccine developed by a U.S-based team could do just that. The vaccine uses a genetically modified version of the parasite that exposes the immune system to the disease without allowing it to develop into full-blown malaria. In initial tests, the vaccine stimulated a response that could block an actual infection without any significant side-effects. The results are promising and has warranted further clinical testing.

Solutions News Source Print this article
More of Today's Solutions

New CFBP regulations erase medical debt from credit reports

BY THE OPTIMIST DAILY EDITORIAL TEAM In a bold move to protect consumers burdened by medical debt, the Consumer Financial Protection Bureau (CFPB) unveiled ...

Read More

A hidden crisis: what LA residents need to know about water safety after wild...

BY THE OPTIMIST DAILY EDITORIAL TEAM As Los Angeles begins to heal from the wildfires that have devastated neighborhoods and left thousands displaced, a ...

Read More

Taking an afternoon nap may make your brain healthier

If you love to indulge in a feel-good siesta, then we have good news for you: those afternoon moments of slumber might be benefiting ...

Read More

Scientists gain ground in the race to reverse aging

So many of us do so much to keep ourselves healthy and live long lives. We exercise, we hydrate, we eat right, and we ...

Read More